Horizon Discovery Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Horizon Discovery's estimated annual revenue is currently $28.4M per year.(i)
  • Horizon Discovery's estimated revenue per employee is $155,000

Employee Data

  • Horizon Discovery has 183 Employees.(i)
  • Horizon Discovery grew their employee count by -55% last year.

Horizon Discovery's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head OperationsReveal Email/Phone
3
Head Global OpsReveal Email/Phone
4
Senior Director, Information TechnologyReveal Email/Phone
5
Director Sales - NA West & Head Bioproduction SalesReveal Email/Phone
6
Financial DirectorReveal Email/Phone
7
Operational Site Director / Executive LeadershipReveal Email/Phone
8
Associate Director Project ManagementReveal Email/Phone
9
Director Manufacturing OperationsReveal Email/Phone
10
Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

What Is Horizon Discovery?

Horizon Discovery (LSE: HZD) is a world-leading gene editing company that designs and engineers genetically-modified cells, applying them in research and clinical applications to advance human health. Horizon's proprietary gene editing platform, able to alter almost any gene sequence, has generated a catalogue of over 23,000 cell and in vivo models that recapitulate the genetic anomalies found in diseases like cancer. These models have been adopted by c1,600 unique organisations to better understand of the genetic drivers of disease, and by Horizon in a range of services offered to customers as well as in the Company's own R&D pipeline.

keywords:N/A

N/A

Total Funding

183

Number of Employees

$28.4M

Revenue (est)

-55%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Horizon Discovery News

2022-04-20 - Clustered Regularly Interspaced Short Palindromic Repeats ...

... Outlook And Forecast | Thermo Fisher Scientific, Merck, GenScript, Integrated DNA Technologies, Horizon Discovery Group, Agilent Technologies, Cellecta,...

2022-04-19 - Genome Editing Market Size, Scope And Forecast | Thermo ...

Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific...

2022-04-17 - Animal Model Market Size And Forecast | Horizon Discovery ...

Horizon Discovery Group plc, Trans Genic Inc, The Jackson Laboratory, Genoway SA, Transposagen Biopharmaceuticals Crown Bioscience Envigo...

2021-03-30 - Horizon Discovery extends gene modulation portfolio

Horizon Discovery extends gene modulation portfolio 30-03-2021 CRISPRi innovations provide expanded experimental options and flexibility for researchers, facilitating disease and drug research. Horizon Discovery, a PerkinElmer, Inc. (NYSE:PKI) company, announced that its gene editing and modu ...

2021-03-30 - Horizon Discovery extends gene modulation portfolio

Horizon Discovery extends gene modulation portfolio 30-03-2021 CRISPRi innovations provide expanded experimental options and flexibility for researchers, facilitating disease and drug research. Horizon Discovery, a PerkinElmer, Inc. (NYSE:PKI) company, announced that its gene editing and modu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A18341%N/A
#2
$42.5M1841%N/A
#3
$35M184N/AN/A
#4
$28.5M1846%N/A
#5
$38.4M1856%$460.4M